
Strides Pharma Science Ltd reported a 51% rise in consolidated net profit at ₹129.28 crore for the fourth quarter ended March 31, 2026, compared to ₹85.62 crore in the year-ago period. According to the company's regulatory filing, revenue from operations stood at ₹1,323.47 crore versus ₹1,190.39 crore in the corresponding quarter of the previous year. The strong performance was primarily driven by robust growth in the company's main markets excluding the US.
The company's revenue from main markets excluding the US was up at ₹645.8 crore compared to ₹480 crore in the year-ago period, as reported in the investor presentation. However, US market revenue declined to ₹646.7 crore from ₹651.5 crore in the previous year, impacted by a weaker flu season in the second half. Total expenses increased to ₹1,178.59 crore from ₹1,071.71 crore in the same period last year.
For the full financial year FY26, consolidated net profit was ₹574.52 crore compared to ₹3,597.51 crore in FY25, which was boosted by a profit after tax from discontinued operations of ₹3,188.11 crore. Revenue from operations stood at ₹4,858.68 crore as against ₹4,565.34 crore in the previous year. The company's performance was primarily driven by strong growth in Ex-US markets, which outpaced overall company growth.
MD & Group CEO Badree Komandur stated that the company continued to deliver strong performance across profitability, efficiency, and growth metrics during FY26, primarily driven by Ex-US markets. As reported by the company, he noted that the calibrated strategy in Ex-US markets is delivering results, with these markets outpacing overall company growth. The US business remained stable during the year, though impacted by a weaker flu season in the second half. Komandur further emphasized that despite ongoing geopolitical uncertainties and a challenging external environment, the company remains committed to delivering long-term sustainable and profitable growth.
The board of directors has recommended a final dividend of ₹5 per equity share of ₹10 each, at the rate of 50% for FY26. According to the company announcement, despite ongoing geopolitical uncertainties and a challenging external environment, the management remains committed to delivering long-term sustainable and profitable growth.